People with schizophrenia may have increased bone fragility risk, finds study Jacinthlyn Sylvia8 Aug 2024 8:15 PM ISTA new study by Behnaz Azimi Manavi and team showed that individuals diagnosed with schizophrenia had markedly reduced bone mineral density (BMD) in...
KarXT shows remarkable safety and efficacy in schizophrenia patients: Lancet Jacinthlyn Sylvia20 Feb 2024 8:00 AM ISTThe medication KarXT represents a significant departure from the conventional antipsychotic drugs by targeting muscarinic receptors instead of...
Brilaroxazine exhibits positive results for Schizophrenia in Phase 3 trial Jacinthlyn Sylvia5 Jan 2024 9:30 AM ISTReviva Pharmaceuticals Holdings, Inc. reported the successful completion of its key Phase 3 RECOVER trial for brilaroxazine, which represents a...
High Prevalence of Sexual Dysfunction in Schizophrenia Patients: JAMA Jacinthlyn Sylvia31 Oct 2023 9:45 AM ISTA comprehensive study published in the Journal of American Medical Association shed light on a widely underexplored issue in the management of...
Focused nutrition improves cardiovascular health of schizophrenic patients: BMC Jacinthlyn Sylvia24 Jan 2023 10:00 AM ISTIn a new study conducted by Alfonso Sevillano-Jimenez and team found that in patients with schizophrenia spectrum illness, the implementation of a...
Amisulpride may help alleviate depressive symptoms in patients with major psychiatric disorder MD Editorial Team18 Nov 2021 9:15 AM ISTDepression is a major public health problem. Though many antidepressant medications are available, a significant proportion of individuals are known...
